Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2017

Open Access 01.12.2017 | Research article

Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591)

verfasst von: Seher Raza Zaidi, Andrea M. Collins, Elena Mitsi, Jesús Reiné, Kayleigh Davies, Angela D Wright, Jessica Owugha, Richard Fitzgerald, Amitava Ganguli, Stephen B Gordon, Daniela Mulari Ferreira, Jamie Rylance

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2017

Abstract

Background

Broncho alveolar lavage (BAL) is widely used for investigative research to study innate, cellular and humoral immune responses, and in early phase drug trials. Conventional (multiple use) flexible bronchoscopes have time and monetary costs associated with cleaning, and carries a small risk of cross infection. Single use bronchoscopes may provide an alternative, but have not been evaluated in this context.

Methods

Healthy volunteers underwent bronchoscopy at a day-case clinical research unit using the Ambu® aScopeTM single-use flexible intubation bronchoscope. Broncho alveolar lavage was performed from a sub segmental bronchus within the right middle lobe; a total of 200 ml of warmed normal saline was instilled then aspirated using handheld suction. BAL volume yield, cell yield and viability were recorded.

Results

Ten volunteers, (mean age 23 years, six male) participated. Bronchoscopies were carried out by one of two senior bronchoscopists, experienced in the technique of obtaining BAL for research purposes. The results were compared to 50 (mean age 23, 14 male) procedures performed using the conventional scope by the same two bronchoscopists. The total volume yield was significantly higher in the disposable group median 152 ml (IQR 141–166 ml) as compared to conventional 124 ml (110–135 ml), p = <0.01. The total cell yield and viability were similar in both groups, with no significant differences.

Conclusions

With single use bronchoscopes, we achieved a larger BAL volume yield than conventional bronchoscopes, with comparable cell yield and viability. Better volume yields can potentially reduce post procedure side effects such as pleuritic chest pain and cough. The risk of cross infection can be eliminated, providing reassurance to researchers and participants. Reduced maintenance requirements can be cost effective. These could potentially be used for early phase drug development studies.

Trial registration

This trial was registered prospectively in July 2015 with the National Clinical Trials register, with the following registration number assigned: NCT 02515591.
Abkürzungen
BAL
Broncho alveolar Lavage
RML
Right Middle Lobe bronchus

Background

Flexible bronchoscopy is widely performed in adults and children for investigation of pulmonary pathology [1, 2]. Broncho alveolar lavage (BAL) sampling is used to study innate, cellular and humoral immune responses, determining the cell population profiles that can facilitate the diagnosis of various diffuse lung diseases [37]. It is used in early phase drug development studies and has a well-proven safety record in both research and in clinical applications. BAL is easily performed and well-tolerated with rare complications [810].
Typically, conventional flexible bronchoscopes are used but they are associated with significant costs related to initial purchase, ongoing maintenance, and sterilisation [11, 12]. Single use bronchoscopes offer an alternative [11] and are currently used in many UK NHS trusts for both emergency and elective airway intubations [13]. Single use scopes are more portable, and might also improve working efficiency [12]. Their efficacy for research studies has not yet been demonstrated, notably in research BAL the cell number and viability, and the returned volume of epithelial lining fluid is critical. Maximising the volume of BAL fluid returned has potential advantages to both researchers and participants: procedures that return less than 100 mL are more frequently associated with side effects such as cough, pleuritic chest pain and fever. Larger total instilled volumes of a minimum of 100 mL and a recommended standard 240 mL using standard 4 × 60 mL aliquots have therefore been recommended by the European Respiratory Society (ERS) to improve standardization when more efficient alveolar sampling and accurate quantitative measurements are required [14]. For cellular studies, function and viability are important, and may be maximised by the use of manual suction which minimises cellular shear forces [8]. Rapid processing by designated laboratory staff highly trained in handling of BALF (BAL fluid) samples is ideal. However, it should be noted that there is no strong relationship between the volumes returned and cell numbers obtained (unpublished data from our group).
This study presents a comparison of single use disposable bronchoscopes and conventional bronchoscopes with regards to BAL volumes, cell yields and viability using each method.

Methods

The aim of the study was to compare the BAL volume yield, total cell yield and viability between samples obtained using single use and conventional bronchoscopes. Table 1 compares different features of the single use and flexible bronchoscopes.
Table 1
Features of Single-use and Multiple Use Bronchoscopes
 
Multiple Use Bronchoscope
Single-use Bronchoscope
Optical Systems
Field of View
120°
85°
Direction of View
Forward Viewing
Forward Viewing
Depth of field
2–100 mm
8–19 mm
Insertion section
Distal end outer diameter
4.8 mm
5.4 mm
Insertion tube outer diameter
4.9 mm
5.0 mm
Working length
600 mm
600 mm
Instrument Channel
2.0 mm
2.0 mm
Risk of cross infection
Yes
No
Potential delay due to cleaning
Yes
No
Cost
Sterilisation
Servicing
Initial equipment cost
Repeated purchase cost
Portability
Depends on location of image processing unit
Can be hand held

Recruitment

We enrolled healthy volunteers aged 18–55 years old, to undergo bronchoscopy using the Ambu® aScopeTM Regular 5.0/2.2 single-use flexible intubation bronchoscope. The study was carried out in the Clinical Research Unit (CRU) at the Royal Liverpool University Hospital (RLUH). The primary aim was to compare the BAL volume yield (mL), cell yield (total cell number) and proportion of viable cells (alveolar macrophages [AM] and lymphocytes), with recent data from procedures using conventional bronchoscopes. Conventional procedures were performed on 50 healthy volunteers recruited at the same site with identical inclusion and exclusion criteria. The demographics are described in Table 2.
Table 2
Demographics
 
Single-use (n = 10)
Conventional (n = 50)
Age (yr) mean ± SD a
23.4 ± 1.8
25.9 ± 4.2
Males (%)
6 (60%)
19 (37.2%)
a Un-paired T-test
A physical examination including vital signs was performed. A detailed history of complications associated with other procedures or trauma was obtained, and risks for bleeding sought according to guidelines [7], specifically medications (e.g. clopidogrel, aspirin, Coumadin, heparin), and relevant medical conditions (e.g. uremia). Exclusion criteria were: a history of allergic reaction to benzodiazepines, or any anaesthetic agent; smoking history of > 10 pack years; any tobacco smoking in the preceding 3 months; pregnancy; abnormalities of screening blood tests (haemoglobin, white cell count, platelets, liver transaminases, bilirubin, renal and clotting profile).

Bronchoscopy and Broncho alveolar lavage

Bronchoscopy was carried out as a day case according to previously published protocol [8]. Briefly, local anaesthesia was attained using topical lidocaine gel and spray, with further 4% lidocaine administered to the larynx and 2% lidocaine to the bronchial tree via the scope. Warmed 0.9% saline was instilled to the right middle lobe in sequential aliquots (60, 50 and 40 mL), with aspiration into a sterile syringe using gentle manual suction. BAL yields were recorded, and fluid transported immediately to the laboratory on melting ice [8]. We used continuous monitoring of heart rate, blood pressure and oxygen saturations during the procedure, with supplemental oxygen given by nasal cannula.
All procedures were carried out by one of two senior bronchoscopists, experienced in obtaining BAL for research purposes. Hospital procedures required that conventional bronchoscopy was performed in the surgical theatres, whereas flexible bronchoscopy was performed in the research ward: this was the only difference between the groups.

Sample processing

BAL fluid (BALF) was filtered through double layered gauze to remove mucus plugs. Cells were pelleted by centrifugation (1500 rpm for 10 min at 4 °C), and washed with 50 mL cold RPMI medium (Gibco™ RPMI 1640 Medium) containing antibiotics (Penicillin, Neomycin and Streptomycin, Sigma-Aldrich, Sigma Chemical Co. St. Louis, MO, USA). The centrifugation step was repeated once, and the cell pellet was re-suspended in culture medium, with the addition of 10% FBS Gibco-Invitrogen (Life Technologies GmbH, Eggenstein, Germany). Cell suspensions were examined as five times diluted in trypan blue for counting and viability assessment using a haemocytometer.

Statistical analysis

Primary outcome measures were compared with values from the preceding 50 conventional procedures using the Mann Whitney U Test. Statistical analyses were performed with Graph Pad Prism version 5.0, Graph Pad Software, La Jolla, CA, USA).

Results

Ten participants (6 male), mean age of 23.4 years (range 20–26 years) were enrolled. All participants were intubated nasally, and only one requested sedation (midazolam 3 mg used). The median BAL volume yield from the single-use bronchoscopes was 152 mL (IQR 141–166 mL) as compared to conventional 124 mL (110–135 mL), p < 0.01 (Fig. 1). The median total cell yield from single-use bronchoscopes was 7.33 × 106 (5.13 × 106–9.80 × 106) compared with 7.0 × 106 (4.53 × 106–1.64 × 107) for conventional procedures, p = 0.61 (Fig. 2). The median cell viability for samples from single use bronchoscopes was 98.5% (93.8–100) compared to 98.2% (93.7–100%), p = 0.75 (Fig. 3). The comparison for the demographics is described in Table 2.

Discussion

Broncho alveolar lavage with single-use flexible bronchoscope achieved greater BAL volume yields than with conventional bronchoscopes. There was no significant difference between the cell yield and viability between the methods.
Single-use bronchoscopes have been evaluated in the critical care setting with favourable evaluation for bronchoscopy, tracheostomy, intubation and suction [11]. Our group has experience of over 1500 research BALs, and the procedures in this study were performed by senior bronchoscopists with extensive experience of BAL for research purposes; allowing good comparison with the use of conventional bronchoscopes. BAL volume yields were similar in male and female participants in our study, as seen in other studies [15].
The greater BAL volume return achieved with single-use bronchoscopes could lead to reduced risk of post-procedural side effects such as cough, pleuritic chest pain and fever, which may improve tolerability and participant comfort. However, we have not systematically collected these data.
Single use flexible bronchoscopes have the potential for use in pharmaceutical preclinical and clinical studies for medicine development.

Conclusion

Single-use flexible bronchoscopes can be used to obtain BAL for research purposes to study immune responses and in early phase drug development studies.

Acknowledgements

We would like to thank all the volunteers for their participation, the staff on the RLUH clinical research unit and in the LSTM laboratory for help and support during the study and also Ambu® for supporting this study, by providing single use flexible bronchoscopes.

Funding

Data for this study was collected with grant support from Bill and Melinda Gates Foundation and the Medical Research Council. Personnel and estates costs were also provided by the clinical research unit at the Royal Liverpool University Hospital and the Liverpool School of Tropical Medicine.

Availability of data and materials

The datasets used and analysed during the current study will be available from the Liverpool school of Tropical Medicine online repository. This can be accessed vis: http://​archive.​lstmed.​ac.​uk/​.

Authors’ contributions

SZ Manuscript writing and drafting, data analysis and interpretation. AC Manuscript writing and drafting, writing study protocol, performing procedures and recruitment. EM Manuscript writing and drafting, sample processing, obtaining data, data analysis and interpretation. KD Manuscript writing and drafting, study protocol, recruitment and assisting in procedures. AW Manuscript writing and drafting, study protocol, recruitment and assisting in procedures. JO Manuscript writing and drafting, sample processing, obtaining data. JR Manuscript writing and drafting, sample processing, obtaining data. RF Manuscript writing and drafting, study protocol, recruitment. AG Manuscript writing and drafting, study protocol, recruitment. SG Manuscript writing and drafting, study protocol. DF Manuscript writing and drafting, study protocol, sample processing, obtaining data, data analysis and interpretation. JR Manuscript writing and drafting, performed procedures, study protocol, recruitment, sample processing, obtaining data, data analysis and interpretation. All authors read and approved the final manuscript.

Competing interests

Authors do not have any competing interests related to this study. The single use, flexible bronchoscopes were provided free of charge for use by Ambu®, with no input in the study design, analysis or manuscript drafting.
Not applicable.
This study was approved by the NHS Research Ethics Committee Liverpool East (REC Reference 15/NW/0019), and participants were consented as per protocol.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Rose AS, Knox KS. Bronchoalveolar lavage as a research tool. Semin Respir Crit Care Med. 2007;28(5):561–73.CrossRefPubMed Rose AS, Knox KS. Bronchoalveolar lavage as a research tool. Semin Respir Crit Care Med. 2007;28(5):561–73.CrossRefPubMed
2.
Zurück zum Zitat Davies J, Payne D. Research applications of bronchoscopy. Paediatr Respir Rev. 2003;4(3):230–6.CrossRefPubMed Davies J, Payne D. Research applications of bronchoscopy. Paediatr Respir Rev. 2003;4(3):230–6.CrossRefPubMed
3.
Zurück zum Zitat Gordon SB, Irving GR, Lawson RA, Lee ME, Read RC. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun. 2000;68(4):2286–93.CrossRefPubMedPubMedCentral Gordon SB, Irving GR, Lawson RA, Lee ME, Read RC. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun. 2000;68(4):2286–93.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Gordon SB, Miller DE, Day RB, Ferry T, Wilkes DS, Schnizlein-Bick CT, et al. Pulmonary Immunoglobulin Responses to Streptococcus pneumoniae Are Altered but Not Reduced in Human Immunodeficiency Virus–Infected Malawian Adults. J Infect Dis. 2003;188(5):666–70.CrossRefPubMed Gordon SB, Miller DE, Day RB, Ferry T, Wilkes DS, Schnizlein-Bick CT, et al. Pulmonary Immunoglobulin Responses to Streptococcus pneumoniae Are Altered but Not Reduced in Human Immunodeficiency Virus–Infected Malawian Adults. J Infect Dis. 2003;188(5):666–70.CrossRefPubMed
5.
Zurück zum Zitat Jambo KC, Sepako E, Fullerton DG, Mzinza D, Glennie S, Wright AK, et al. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax. 2011;66(5):375–82.CrossRefPubMedPubMedCentral Jambo KC, Sepako E, Fullerton DG, Mzinza D, Glennie S, Wright AK, et al. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax. 2011;66(5):375–82.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Eagan R, Twigg HL, French N, Musaya J, Day RB, Zijlstra EE, et al. Lung Fluid Immunoglobulin from HIV-Infected Subjects Has Impaired Opsonic Function against Pneumococci. Clin Infect Dis. 2007;44(12):1632–8.CrossRefPubMed Eagan R, Twigg HL, French N, Musaya J, Day RB, Zijlstra EE, et al. Lung Fluid Immunoglobulin from HIV-Infected Subjects Has Impaired Opsonic Function against Pneumococci. Clin Infect Dis. 2007;44(12):1632–8.CrossRefPubMed
7.
Zurück zum Zitat Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.CrossRefPubMed Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.CrossRefPubMed
8.
Zurück zum Zitat Collins AM, Rylance J, Wootton DG, Wright AD, Wright AKA, Fullerton DG, et al. Bronchoalveolar Lavage (BAL) for Research; Obtaining Adequate Sample Yield. Journal of Visualised Experiments. 2014;(85):e4345. doi:10.3791/4345. Collins AM, Rylance J, Wootton DG, Wright AD, Wright AKA, Fullerton DG, et al. Bronchoalveolar Lavage (BAL) for Research; Obtaining Adequate Sample Yield. Journal of Visualised Experiments. 2014;(85):e4345. doi:10.​3791/​4345.
9.
Zurück zum Zitat Strumpf IJ, Feld MK, Cornelius MJ, Keogh BA, Crystal RG. Safety of Fiberoptic Bronchoalveolar Lavage in Evaluation of Interstitial Lung Disease. Chest. 1981;80(3):268–71.CrossRefPubMed Strumpf IJ, Feld MK, Cornelius MJ, Keogh BA, Crystal RG. Safety of Fiberoptic Bronchoalveolar Lavage in Evaluation of Interstitial Lung Disease. Chest. 1981;80(3):268–71.CrossRefPubMed
10.
Zurück zum Zitat Begara I, Luján L, McLaren L, Collie DDS, Miller HRP, Watt NJ. Quantitation of transforming growth factor-β in plasma and pulmonary epithelial lining fluid of sheep experimentally infected with maedi-visna virus. Vet Immunol Immunopathol. 1995;48(3):261–73.CrossRefPubMed Begara I, Luján L, McLaren L, Collie DDS, Miller HRP, Watt NJ. Quantitation of transforming growth factor-β in plasma and pulmonary epithelial lining fluid of sheep experimentally infected with maedi-visna virus. Vet Immunol Immunopathol. 1995;48(3):261–73.CrossRefPubMed
11.
Zurück zum Zitat Mankikian J, Ehrmann S, Guilleminault L, Le Fol T, Barc C, Ferrandiere M, et al. An evaluation of a new single-use flexible bronchoscope with a large suction channel: reliability of bronchoalveolar lavage in ventilated piglets and initial clinical experience. Anaesthesia. 2014;69(7):701–6.CrossRefPubMed Mankikian J, Ehrmann S, Guilleminault L, Le Fol T, Barc C, Ferrandiere M, et al. An evaluation of a new single-use flexible bronchoscope with a large suction channel: reliability of bronchoalveolar lavage in ventilated piglets and initial clinical experience. Anaesthesia. 2014;69(7):701–6.CrossRefPubMed
12.
Zurück zum Zitat Colt HG, Beamis JJ, Harrell JH, Mathur PM. Novel flexible bronchoscope and single-use disposable-sheath endoscope system. A preliminary technology evaluation. Chest. 2000;118(1):183–7.CrossRefPubMed Colt HG, Beamis JJ, Harrell JH, Mathur PM. Novel flexible bronchoscope and single-use disposable-sheath endoscope system. A preliminary technology evaluation. Chest. 2000;118(1):183–7.CrossRefPubMed
13.
Zurück zum Zitat Pujol E, López AM, Valero R. Use of the Ambu® aScope™ in 10 patients with predicted difficult intubation. Anaesthesia. 2010;65(10):1037–40.CrossRefPubMed Pujol E, López AM, Valero R. Use of the Ambu® aScope™ in 10 patients with predicted difficult intubation. Anaesthesia. 2010;65(10):1037–40.CrossRefPubMed
14.
Zurück zum Zitat Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J. 1999;14(2):245–8.CrossRefPubMed Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J. 1999;14(2):245–8.CrossRefPubMed
15.
Zurück zum Zitat Olsen HH, Grunewald J, Tornling G, Sköld CM, Eklund A. Bronchoalveolar Lavage Results Are Independent of Season, Age, Gender and Collection Site. PLoS ONE. 2012;7(8):e43644.CrossRefPubMedPubMedCentral Olsen HH, Grunewald J, Tornling G, Sköld CM, Eklund A. Bronchoalveolar Lavage Results Are Independent of Season, Age, Gender and Collection Site. PLoS ONE. 2012;7(8):e43644.CrossRefPubMedPubMedCentral
Metadaten
Titel
Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591)
verfasst von
Seher Raza Zaidi
Andrea M. Collins
Elena Mitsi
Jesús Reiné
Kayleigh Davies
Angela D Wright
Jessica Owugha
Richard Fitzgerald
Amitava Ganguli
Stephen B Gordon
Daniela Mulari Ferreira
Jamie Rylance
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2017
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-017-0421-7

Weitere Artikel der Ausgabe 1/2017

BMC Pulmonary Medicine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.